This guideline describes the recommended protocols for detecting hemoglobinopathies and thalassemias by population-based newborn screening using dried blood spot specimens. Early, presymptomatic detection to identify newborns with abnormal hemoglobins is critical because it improves treatment effectiveness.
More Standards PDF
CSA B45.9-18/ASME A112.3.4-2018 (R2022)
$40.00 $80.00
CSA B342-18 (R2023)
$70.00 $140.00
CGA S-8
$20.00 $41.00
CSA ANSI LNG 3.10-2018
$75.00 $150.00